Skip to content
★ Sign in to follow
Guangzhou LBP Medicine Science & Technology Co., Ltd. logo

Guangzhou LBP Medicine Science & Technology Co., Ltd. Stock: price and insider trades · China

安必平

CN·Mcap CN¥1.8BHealth Care

No insider purchase over the last 90 days. The latest, by 朱俊轩, was filed 19 Sept 2024.

Guangzhou LBP Medicine Science & Technology Co., Ltd.: what insiders have been doing

Guangzhou LBP Medicine Science & Technology Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). From 4 November 2025 to 4 November 2026, the disclosure feed for Guangzhou LBP Medicine Science & Technology Co., Ltd. logged 1 filing by 1 insider.

The flow runs one way only: 1 sale worth €2,096, from 1 insider, and no purchase. One trade stands out by size: a sale of €2,096 from 朱俊轩, disclosed on 27 April 2026.

Compared with its exchange (517 companies, median 2 filings), a count of 1 filing is below the norm. Our records for Guangzhou LBP Medicine Science & Technology Co., Ltd. go back to 2023, with 4 purchases and 3 sales on the open market in total.

Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
7
Thresholds
n/a
Buy Volume
€4,991
4 ops. · all time
Sell Volume
€18,593
3 ops. · all time

Who traded when

BuySale
朱俊轩1 sale

Since the insiders bought

  • Filed 19 Sept 2024 · 780 days ago · €1,824
    +86.4%
    Entry CN¥14.30 · Close at T+365 CN¥26.65

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 19,274 of 26,914 companies
37.0
score / 100
Value
35
Quality
39
FCF yld0.9%
Earn yld-2.6%
EV/EBITDA·
ROE-3.1%
Gross mgn64%
Net mgn-14%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥19.22
Analyst consensus
·
Income statement
RevenueCN¥344.4M
Gross profitCN¥219.2M64% margin
EBITDA-CN¥12M-3% margin
Net income-CN¥47M-9.5% margin
Valuation
P/Book1.6x
Beta0.47
Balance sheet & cash
Market capCN¥1.8B
Total debtCN¥3.1M
Free Cash FlowCN¥16.9M
Debt / Equity0%
Profitability & ownership
ROE-3.1%
ROA-2.4%
% insiders48.4%
% institutions6.8%
Last declaration on 27 April 2026
Declarations7 total
  • ▼
    核心技术人员Executives
    16,765 CNY4SSE
    700 shares16.7% of flowA股XSHGSSE:273000000524335000
  • ▼
    核心技术人员Executives
    42,415 CNY6SSE
    2,500 shares43.6% of flowA股XSHGSSE:173000008150735680
  • ▲
    核心技术人员Executives
    14,392 CNY3SSE
    1,000 shares14.5% of flowA股XSHGSSE:173000008109360770
    Canonical exit: 18 Dec 2024 (T+90)
  • ▲
    核心技术人员Executives
    7,170 CNY3SSE
    500 shares7.3% of flowA股XSHGSSE:173000007823954620
    Canonical exit: 3 Oct 2024 (T+90)
  • ▲
    董事Executives
    8,121 CNY8SSE
    500 shares8.4% of flowA股XSHGSSE:173000007726355620
    Canonical exit: 2 Sept 2024 (T+90)
  • ▲
    核心技术人员Executives
    9,280 CNY3SSE
    500 shares9.6% of flowA股XSHGSSE:173000007673361500
    Canonical exit: 15 Aug 2024 (T+90)
  • ▼
    83,966 CNY15SSE
    2,700 shares100.0% of flowA股XSHGSSE:173000006638916540

7 of 7 declarations

About Guangzhou LBP Medicine Science & Technology Co., Ltd.

安必平 is a company operating in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations